patients

Ukrainian President Volodymyr Zelensky addressed the United Nations General Assembly, branding Vladimir Putin 'Patient Zero' of the war's disinformation and urging stronger global action on the Russia-Ukraine conflict. He also appealed to the United States, with references to Donald Trump drawing attention as audiences debate how Western support for Kyiv may shift under changing political leadership.

A new Ebola emergency in the Democratic Republic of the Congo is prompting calls from the United Nations and humanitarian organisations for urgent access to affected communities. Aid agencies say rapid, unimpeded access is essential to contain the outbreak, treat patients and deliver supplies, amid concerns that access restrictions could allow the virus to spread further.

American doctors are working inside Gaza, providing medical care amid the territory's ongoing humanitarian and health crisis. Reports highlight the role of US medical volunteers treating wounded patients in hospitals that are short on supplies and staff. The presence of American physicians has drawn attention to the scale of medical need in the enclave and the conditions under which local and foreign health workers operate.

A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to concerns about the lasting effects of infection. The finding points to a broader long-term health burden beyond long COVID itself, with implications for patients managing chronic conditions and for health systems assessing ongoing care needs.

A blood pressure medication has been recalled across the United States, with the FDA classifying the action as a Class II risk level, meaning exposure could cause temporary or medically reversible health consequences. News outlets including WPRI and The Hill reported the nationwide recall, prompting patients taking blood pressure drugs to check whether their prescription is affected.

Drugs like Ozempic and Wegovy were originally developed and described as obesity treatments for patients with medical need, but they are increasingly marketed and used as lifestyle drugs for customers seeking cosmetic or wellness benefits. Commentators note this reframing raises questions about access for people with genuine medical need, pricing, and how the pharmaceutical industry positions these medicines.

Members of Congress are pressing Oracle for answers about a sharp cost increase in the Department of Veterans Affairs' electronic health records modernization, now valued at roughly $17 billion. Lawmakers want details on why the price has grown so substantially and how the troubled program is being managed. The program has faced repeated delays, cost overruns and patient safety concerns since its rollout, drawing ongoing scrutiny from oversight committees.

New research into diabetes suggests that keeping blood sugar levels extremely stable may come at a cost, challenging the assumption that tighter control is always better for patients. The findings are drawing attention among clinicians and people managing diabetes, who are weighing what the results could mean for treatment targets and everyday glucose management advice.

A new study finds that people who stop taking GLP-1 weight-loss and diabetes drugs, such as Ozempic and Wegovy, may face an increased risk of heart attack and stroke. The findings suggest the cardiovascular benefits of these medications depend on continued use, raising questions about how patients should manage long-term treatment.

A new study reported by ScienceDaily suggests glucosamine, a widely used joint supplement taken by millions for arthritis and cartilage pain, may be associated with faster progression of Alzheimer's disease. The findings challenge the supplement's generally assumed safety benefits and are prompting discussion among researchers, patients and caregivers about whether people with cognitive decline should reconsider taking it.

New research suggests donor hearts may take on the biological age of their recipients after transplantation, rather than retaining the age of the original donor. Reported by Scientific American, the finding could reshape how doctors think about organ aging, rejection risk and long-term outcomes for transplant patients.

Taylor Swift has released a music video for 'Patient Zero' that ends with a horror movie-style twist, according to TODAY.com. The ending has prompted discussion among fans about its meaning and how it ties into the song. Details of the twist and the video's storyline have not been widely reported beyond the initial coverage.

Wards at a hospital have been closed following a scabies outbreak, according to BBC and Yahoo News reports. Scabies, a contagious skin infestation caused by mites, spreads quickly in healthcare settings, and closures are typically used to allow deep cleaning and prevent transmission between patients and staff. Details on which hospital is affected, how many cases have been confirmed, and when the wards will reopen have not yet been made clear.

Researchers report that fundamental kinematic indicators—the basic motion patterns of a surgeon's hands during robot-assisted procedures—can predict both levels of surgical expertise and clinical outcomes for patients. The findings, published in Nature, suggest objective movement data could be used to assess and train surgeons, moving evaluation beyond subjective supervision and toward measurable performance benchmarks in robotic surgery.

A growing debate is unfolding over legal responsibility when artificial intelligence systems used in healthcare make errors. As AI tools move into diagnosis and treatment decisions, questions are mounting over whether doctors, hospitals, drugmakers or software developers should be held accountable when a wrong recommendation harms a patient, and regulators have yet to offer clear answers.

The Make America Healthy Again movement is pushing to give Americans far easier access to their personal health data, according to reporting by STAT. The push would let patients obtain and share their medical records more freely, a goal that has drawn attention from both patient advocates and privacy critics as the Trump administration's health agenda advances.